Here we have carcinogenesis. A very important
topic for you in medicine in general.
You understand this chapter in which I will organise your
thoughts for you with all the different ways in which
through a flow chart, I will show you as to how
a particular organ may then develop cancer.
Once you have this understood, then everything else
in all the other organ systems in pharmacology,
will be that much simpler. The fundamentals of carcinogenesis.
It does not have to be a lethal genetic damage.
And by that I mean that there could be non-lethal issues.
Remember that you could have just one mutation taking
place, and may be developing cancer. For example, if you
have a translocation of 9 and 22 developing
chronic myelogenous leukaemia, there is one translocation
which develop the cancer and you as a clinician,
will be taking advantage of that. Meaning to say that
you are going to use a drug such as imatinib,
that inhibit the tyrosine kinase and cure
your cancer. However, most of your cancers
require multifactorial type of mutations. May be p53, may be
RAS, being very common mutations eventually leading into cancer
down the line. Now there are four classes of normal
regulatory genes that are often damaged
and therefore going on to developing neoplasia.
Growth promoting oncogenes.
At some point, we will go through what's known as
proto-oncogenes which are perfectly normal.
Responsible for maturation and growth
of normal organs within us.
At some point in time those proto-oncogenes may
then become mutated, and thus become oncogenes.
You have heard of c-myc with Burrkitt's lymphoma.
It is an example of an oncogene.
Growth inhibiting tumor suppressor genes. Now, tumor suppressor
genes are like guardians for us in our ccell cycle.
For example, you have heard of p53 and Rb. Those would
be the most famous of the tumor suppressor genes.
There are however a few more
that we need to keep in mind.
Now imagine, that the security guards
are then removed from your cycle.
There is nothing preventing a bad call to go through
the cell cycle resulting in eventually, cancer.
Genes that regulate apoptosis. Here, keep in mind
that cancer would not want apoptosis.
Cancer wishes and often times is successful in
finding the 'fountain of youth'.
Forever will remain. Therefore, carcinogenesis would
mean that it has found a way to evade apoptosis.
For example, if I tell you translocation of 14 and 18,
reflexively you will tell me about follicular lymphoma.
Reflexively you will tell me about upregulation of
BCL2. That BCL2, will prevent the release of your
cytochrome c. You will not activate caspase,
thus you will not have apoptosis.
Genes involved in DNA repair. Often times you
will have DNA repair genes and at some point
we will talk about an example from biochemistry,
of a pathology called xeroderma pigmentosa,
in which there is an excision repair mutation,
resulting in lack of proper repair of the DNA.
And if this then continues through the cell cycle, guess
what, will or would perhaps then develop cancer.
Most of your cancers as I said, will be multi-step in
process or the evolution of the cancers.
Put it that way. And by that I mean once again, maybe
there is a mutation that initially took place with RAS.
Even before that, maybe there is a mutation in which
patient was exposed to whatever type of carcinogen.
That we will take a look at in terms of a chemical. Usually
will be multi-step. There are exceptions to that.
I gave you one such as CML. Another one, called
melanoma, in which once again here,
if you are able to inhibit BRAF, you might
actually be able to treat melanoma.
In which it's just one mutation. Tumors arise from clonal
expansion of single genetic damaged precursor cell.
In other words, most of your cancers will exhibit
a phenomenon called monoclonality.
Lots to talk about in carcinogenesis. All I am doing right
now is laying down the foundation of things to come,
and we will go into great detail, and obviously I
will give you specific cancers.